<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>46</viewCount><searchCount>0</searchCount></scores><additional><submitter>Caselli RJ</submitter><funding>NIA NIH HHS</funding><pagination>284-290</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6249104</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>32(4)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Roughly 4% to 23% of the population embody stress prone personality and other traits characterizing a subclinical "broad autism phenotype" (BAP). Subjective cognitive impairment (SCI) among healthy elderly is associated with psychological distress leading us to predict BAP would be associated with SCI.&lt;h4>Methods&lt;/h4>The Autism Spectrum Quotient, a self-administered 50 item questionnaire, was completed by 419 consecutive members of the Arizona APOE Cohort who underwent neuropsychological testing every 2 years. SCI was assessed with self and informant versions of the Multidimensional Assessment of Neurodegenerative Symptoms (MANS) Questionnaire.&lt;h4>Results&lt;/h4>A total of 45 individuals scored in the BAP range, designated BAP+, and the rest were BAP-. At entry, both Multidimensional Assessment of Neurodegenerative Symptoms Questionnaire Self and Informant scores were higher in the BAP+ group (P&lt;0.0001). After age 60, the BAP+ group had greater annual increases in Multidimensional Assessment of Neurodegenerative Symptoms Questionnaire Self scores (0.05 vs. 0.02; difference=0.03; 95% confidence interval, 0.004-0.05; P=0.02) yet there was no difference between groups in memory decline. Over ~10 years 33 individuals developed mild cognitive impairment: 4 in the BAP+ group (8.9%) and 29 in the BAP- group (7.8%), P=0.77.&lt;h4>Discussion&lt;/h4>Individuals who meet criteria for the BAP have escalating SCI with age, but no greater rate of memory decline or clinical progression to mild cognitive impairment.</pubmed_abstract><journal>Alzheimer disease and associated disorders</journal><pubmed_title>Subjective Cognitive Impairment and the Broad Autism Phenotype.</pubmed_title><pmcid>PMC6249104</pmcid><funding_grant_id>P30 AG019610</funding_grant_id><funding_grant_id>R01 AG031581</funding_grant_id><pubmed_authors>Dueck AC</pubmed_authors><pubmed_authors>Woodruff BK</pubmed_authors><pubmed_authors>Langlais BT</pubmed_authors><pubmed_authors>Locke DEC</pubmed_authors><pubmed_authors>Caselli RJ</pubmed_authors><view_count>46</view_count></additional><is_claimable>false</is_claimable><name>Subjective Cognitive Impairment and the Broad Autism Phenotype.</name><description>&lt;h4>Introduction&lt;/h4>Roughly 4% to 23% of the population embody stress prone personality and other traits characterizing a subclinical "broad autism phenotype" (BAP). Subjective cognitive impairment (SCI) among healthy elderly is associated with psychological distress leading us to predict BAP would be associated with SCI.&lt;h4>Methods&lt;/h4>The Autism Spectrum Quotient, a self-administered 50 item questionnaire, was completed by 419 consecutive members of the Arizona APOE Cohort who underwent neuropsychological testing every 2 years. SCI was assessed with self and informant versions of the Multidimensional Assessment of Neurodegenerative Symptoms (MANS) Questionnaire.&lt;h4>Results&lt;/h4>A total of 45 individuals scored in the BAP range, designated BAP+, and the rest were BAP-. At entry, both Multidimensional Assessment of Neurodegenerative Symptoms Questionnaire Self and Informant scores were higher in the BAP+ group (P&lt;0.0001). After age 60, the BAP+ group had greater annual increases in Multidimensional Assessment of Neurodegenerative Symptoms Questionnaire Self scores (0.05 vs. 0.02; difference=0.03; 95% confidence interval, 0.004-0.05; P=0.02) yet there was no difference between groups in memory decline. Over ~10 years 33 individuals developed mild cognitive impairment: 4 in the BAP+ group (8.9%) and 29 in the BAP- group (7.8%), P=0.77.&lt;h4>Discussion&lt;/h4>Individuals who meet criteria for the BAP have escalating SCI with age, but no greater rate of memory decline or clinical progression to mild cognitive impairment.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Oct-Dec</publication><modification>2024-11-20T05:24:18.217Z</modification><creation>2019-10-11T07:18:30Z</creation></dates><accession>S-EPMC6249104</accession><cross_references><pubmed>30211704</pubmed><doi>10.1097/WAD.0000000000000273</doi><doi>10.1097/wad.0000000000000273</doi></cross_references></HashMap>